Detailed financial profiles of 75+ venture-backed biopharma startups that went public in 2018 and 2019
Estimated valuations of 150+ private venture rounds
Amount invested in each round by major venture investors
Breakdown of R&D spend by program and functional area
Company info: therapeutic area, development stage, therapeutic modality, and more
IPO info: proceeds, valuation, underwriters, post-IPO performance, and more
Get an information advantage with estimated valuations of over 150 recent venture investments in biopharma startups.
Benchmark your financial plan with data on R&D and SG&A spend for 75+ startups.
Includes breakdown of R&D spend by functional area for 50+ companies.
Understand how much potential investors invest, and at what valuation, with data on venture investments by major investors.
All reports are 30% off through January 17, 2020
Profiles of 79 VC-backed biopharma startups that raised at least $50M in US IPOs in 2018 and 2019
If you are not satisfied with your purchase, let us know how we can improve and we will give you a full refund.
Our data is provided in excel. All data is manually reviewed before inclusion into our database to ensure quality.
Our data is drawn from publicly available sources. Not all data is available for all companies.
Valuation data is estimated based on preferred price per share, common shares outstanding, options in the option pool, and other dilutive shares (warrants, shares issued as consideration for license agreements, etc.). For more about our methodology, contact us using the form below.